Regulation of agricultural genome editing using crispr-cas systems

Introduction

CRISPR-Cas systems are advanced genome-editing technologies used to make targeted changes in the DNA of living organisms. In agriculture, these technologies can improve crop productivity, disease resistance, nutritional quality, drought tolerance and adaptability to changing climatic conditions. Unlike conventional genetic engineering, certain CRISPR-based techniques can introduce targeted genetic changes without necessarily incorporating foreign DNA into the final plant.

The regulation of agricultural genome editing is important because these technologies may affect food safety, biodiversity, environmental protection, farmers' rights and intellectual property. Governments must establish appropriate regulatory systems to encourage agricultural innovation while preventing potential risks to human health and the environment.

Meaning and applications of CRISPR-Cas technology

CRISPR stands for Clustered Regularly Interspaced Short Palindromic Repeats. The CRISPR-Cas system uses a guide RNA to direct a Cas enzyme, commonly Cas9, towards a specific DNA sequence. The enzyme creates a targeted modification, which may result in the deletion, insertion or alteration of genetic material.

Agricultural applications include:

Developing crops resistant to fungal, bacterial and viral diseases.

Improving tolerance to drought, salinity and extreme temperatures.

Increasing nutritional value and shelf life.

Reducing susceptibility to agricultural pests.

Improving crop productivity and resource efficiency.

Developing varieties with reduced dependence on certain chemical inputs.

These applications can support food security, but their environmental and agricultural consequences require scientific evaluation.

Legal framework in India

The principal regulatory framework for genetically modified organisms in India is the Environment (Protection) Act, 1986, and the Rules for the Manufacture, Use, Import, Export and Storage of Hazardous Microorganisms, Genetically Engineered Organisms or Cells, 1989.

These rules regulate activities involving genetically engineered organisms and provide for several regulatory authorities:

1. Genetic Engineering Appraisal Committee (GEAC): It is responsible for appraisal of activities involving large-scale use and environmental release of genetically engineered organisms, including approvals within its statutory jurisdiction.

2. Review Committee on Genetic Manipulation (RCGM): It monitors safety-related research and development activities involving genetically engineered organisms and operates under the Department of Biotechnology.

3. Institutional Biosafety Committees (IBSCs): These committees supervise institutional research involving genetically engineered organisms and ensure compliance with applicable biosafety requirements.

4. State Biotechnology Coordination Committees and District Level Committees: These authorities support monitoring, inspection and enforcement under the 1989 Rules.

An important regulatory development occurred in March 2022, when the Ministry of Environment, Forest and Climate Change issued an exemption for certain genome-edited plants developed through Site-Directed Nuclease-1 (SDN-1) and Site-Directed Nuclease-2 (SDN-2) techniques, subject to specified conditions. Such plants may be exempted from the relevant provisions of the 1989 Rules where the prescribed requirements are satisfied, including the absence of exogenous introduced DNA in the final product.

The exemption does not automatically cover every CRISPR-Cas application. Regulatory treatment depends on the editing technique, characteristics of the resulting organism and applicable government guidelines.

International regulatory principles

Internationally, agricultural genome editing is governed through different regulatory approaches.

The Cartagena Protocol on Biosafety, 2000, establishes a framework for the safe handling, transfer and use of living modified organisms resulting from modern biotechnology that may adversely affect biodiversity, taking account of risks to human health.

The Convention on Biological Diversity, 1992, provides broader principles concerning biodiversity conservation and sustainable use.

The Codex Alimentarius guidelines on foods derived from recombinant-DNA plants provide internationally recognised principles for food-safety assessment. Their relevance to genome-edited foods depends on the characteristics of the resulting product and the applicable regulatory framework.

Different jurisdictions follow different approaches. Some regulate genome-edited crops according to the modification technique, while others focus more heavily on the characteristics of the final product.

Food safety and environmental assessment

CRISPR-Cas technology requires appropriate scientific evaluation before agricultural release. Although targeted editing can reduce certain uncertainties associated with conventional genetic modification, unintended genetic changes and environmental effects remain possible.

Regulatory authorities may examine:

Potential toxicity and allergenicity.

Nutritional composition and food quality.

Unintended genetic alterations.

Effects on non-target organisms.

Possibility of gene flow to related plant varieties.

Effects on biodiversity and agricultural ecosystems.

Stability of the intended genetic modification.

Risk assessment should be proportionate to the characteristics and intended use of the edited crop rather than assuming that all genome-edited organisms have identical risks.

Important case laws

1. Aruna Rodrigues v. Union of India, (2012) 5 SCC 764

The Supreme Court considered concerns relating to genetically modified crops, particularly Bt brinjal, and the adequacy of biosafety assessment. The proceedings highlighted the importance of scientific scrutiny, regulatory transparency and environmental protection before permitting genetically modified crops for commercial cultivation. The principles are relevant to CRISPR-edited crops because genome-editing technologies also require appropriate biosafety evaluation.

2. A.P. Pollution Control Board v. Prof. M.V. Nayudu (1999) 2 SCC 718

The Supreme Court discussed the precautionary principle and the importance of scientific expertise in environmental decision-making. The judgment is relevant to agricultural genome editing because regulatory authorities must consider scientific uncertainty and potential environmental consequences before allowing activities that may affect ecosystems.

3. Vellore Citizens' Welfare Forum v. Union of India (1996) 5 SCC 647

The Supreme Court recognised the precautionary principle and sustainable development as important elements of Indian environmental law. These principles support preventive assessment of possible environmental risks associated with the release of genome-edited agricultural organisms.

4. Monsanto Technology LLC v. Nuziveedu Seeds Ltd. (2019) 3 SCC 381

The Supreme Court considered patent-related disputes involving genetically modified cotton technology and the relationship between patent law and plant variety protection. The judgment is relevant to agricultural biotechnology because it illustrates the complexity of intellectual property rights involving genetic technologies and agricultural products. It did not directly decide the regulatory status of CRISPR-edited crops.

Intellectual property and farmers' rights

CRISPR-Cas technology also raises questions concerning patent ownership, licensing and access to agricultural innovations. Under the Patents Act, 1970, inventions must satisfy statutory requirements of novelty, inventive step and industrial applicability.

Section 3(j) excludes plants and animals in whole or any part thereof, other than microorganisms, including seeds, varieties and species, and essentially biological processes for production or propagation of plants and animals, from patentability.

The Protection of Plant Varieties and Farmers' Rights Act, 2001, provides a separate framework for plant variety protection. It recognises breeders' rights while also protecting farmers' interests, including specified rights concerning saving, using, sowing, resowing, exchanging and sharing farm produce or seed, subject to statutory conditions.

Challenges and regulatory safeguards

The regulation of CRISPR-edited crops faces several challenges, including difficulties in identifying certain edits, cross-border differences in regulatory classification, patent disputes and concerns about access to technology.

India should strengthen regulatory transparency through clear approval procedures, scientific risk assessment, institutional biosafety supervision and public disclosure of relevant regulatory decisions. Small farmers should also have reasonable access to improved crop varieties without facing excessive licensing barriers.

Conclusion

The regulation of agricultural genome editing using CRISPR-Cas systems requires a balanced approach that promotes scientific innovation while protecting food safety, biodiversity and farmers' rights. India's Environment (Protection) Act, 1986, the 1989 Rules and the 2022 exemption framework provide the principal regulatory foundation for relevant genome-editing activities. Judicial decisions such as Aruna Rodrigues v. Union of India and Vellore Citizens' Welfare Forum v. Union of India reinforce the importance of scientific assessment and the precautionary principle. A transparent, risk-based regulatory system is essential to ensure that CRISPR technology contributes to sustainable agriculture and long-term food security.